Grandfield & Dodd’s Seagen Inc. Common Stock SGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15,113
| Closed | -$3.21M | – | 200 |
|
|
2023
Q3 | $3.21M | Sell |
15,113
-235
| -2% | -$46.9K | 0.24% | 64 |
|
|
2023
Q2 | $2.95M | Sell |
15,348
-55
| -0.4% | -$10.9K | 0.21% | 68 |
|
|
2023
Q1 | $3.12M | Buy |
15,403
+257
| +2% | +$41.2K | 0.22% | 70 |
|
|
2022
Q4 | $1.95M | Buy |
15,146
+394
| +3% | +$50.8K | 0.14% | 76 |
|
|
2022
Q3 | $2.02M | Buy |
14,752
+50
| +0.3% | +$8.15K | 0.16% | 74 |
|
|
2022
Q2 | $2.6M | Sell |
14,702
-7
| -0% | -$1.01K | 0.2% | 70 |
|
|
2022
Q1 | $2.12M | Buy |
14,709
+269
| +2% | +$36.4K | 0.14% | 76 |
|
|
2021
Q4 | $2.23M | Buy |
14,440
+426
| +3% | +$71.3K | 0.14% | 76 |
|
|
2021
Q3 | $2.38M | Sell |
14,014
-795
| -5% | -$124K | 0.17% | 72 |
|
|
2021
Q2 | $2.34M | Buy |
14,809
+15
| +0.1% | +$2.23K | 0.16% | 72 |
|
|
2021
Q1 | $2.05M | Buy |
14,794
+68
| +0.5% | +$11K | 0.15% | 73 |
|
|
2020
Q4 | $2.58M | Buy |
14,726
+101
| +0.7% | +$18.8K | 0.2% | 69 |
|
|
2020
Q3 | $2.86M | Buy |
14,625
+69
| +0.5% | +$11.6K | 0.26% | 67 |
|
|
2020
Q2 | $2.47M | Buy |
14,556
+465
| +3% | +$69.4K | 0.24% | 67 |
|
|
2020
Q1 | $1.63M | Buy |
14,091
+281
| +2% | +$31.1K | 0.19% | 71 |
|
|
2019
Q4 | $1.58M | Buy |
13,810
+575
| +4% | +$61K | 0.14% | 80 |
|
|
2019
Q3 | $1.13M | Buy |
13,235
+1,010
| +8% | +$74K | 0.11% | 87 |
|
|
2019
Q2 | $846K | Buy |
12,225
+765
| +7% | +$53.6K | 0.08% | 100 |
|
|
2019
Q1 | $839K | Buy |
11,460
+145
| +1% | +$10.3K | 0.09% | 102 |
|
|
2018
Q4 | $641K | Buy |
11,315
+144
| +1% | +$9.03K | 0.08% | 108 |
|
|
2018
Q3 | $862K | Buy |
11,171
+95
| +0.9% | +$7K | 0.09% | 104 |
|
|
2018
Q2 | $735K | Buy |
11,076
+70
| +0.6% | +$4.01K | 0.08% | 110 |
|
|
2018
Q1 | $576K | Sell |
11,006
-350
| -3% | -$19.1K | 0.06% | 116 |
|
|
2017
Q4 | $608K | Buy |
11,356
+270
| +2% | +$15.8K | 0.06% | 120 |
|
|
2017
Q3 | $603K | Buy |
11,086
+1,085
| +11% | +$55.5K | 0.07% | 118 |
|
|
2017
Q2 | $517K | Buy |
10,001
+495
| +5% | +$31.5K | 0.06% | 130 |
|
|
2017
Q1 | $598K | Buy |
9,506
+95
| +1% | +$5.93K | 0.07% | 113 |
|
|
2016
Q4 | $497K | Buy |
9,411
+830
| +10% | +$49.9K | 0.06% | 123 |
|
|
2016
Q3 | $463K | Buy |
8,581
+580
| +7% | +$27.5K | 0.06% | 124 |
|
|
2016
Q2 | $323K | Buy |
8,001
+413
| +5% | +$15.7K | 0.05% | 144 |
|
|
2016
Q1 | $266K | Buy |
+7,588
| New | +$255K | 0.04% | 149 |
|
Other funds holding SGEN
SCM
IA
BTI
FBC
VWA
SAG
Grandfield & Dodd's SGEN Position: Q4 2023 in Review
Grandfield & Dodd sold out of Seagen Inc. Common Stock (SGEN) in Q4 2023, closing a stake of 15,113 shares — an estimated $3.21M sold.
Grandfield & Dodd first reported a position in SGEN in Q1 2016 and held it in 31 quarters. The position peaked at $3.21M in Q3 2023. 6 funds tracked by Wall St. Rank hold SGEN as of Q4 2023.
- Grandfield & Dodd reported no remaining Seagen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Grandfield & Dodd sold 15,113 Seagen Inc. Common Stock shares in Q4 2023, an estimated $3.21M.
- Grandfield & Dodd first reported a position in Seagen Inc. Common Stock in Q1 2016 and held it in 31 quarters.
- Grandfield & Dodd's Seagen Inc. Common Stock position peaked at $3.21M in Q3 2023.
- 6 funds tracked by Wall St. Rank held Seagen Inc. Common Stock as of Q4 2023.
Based on Grandfield & Dodd's 13F filing for Q4 2023, filed 31 Jan 2024.